XENON PHARMACEUTICALS INC. (XENE) Operating cash flow 2016–2025
XENON PHARMACEUTICALS INC. (XENE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$279.1MFY2025 · since FY2016: -$19.6M → -$279.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$279.1M | -53.9% |
| FY2024 | -$181.4M | -20.0% |
| FY2023 | -$151.1M | -49.6% |
| FY2022 | -$101.0M | -45.4% |
| FY2021 | -$69.5M | -44.4% |
| FY2020 | -$48.1M | -920.9% |
| FY2019 | -$4.7M | +86.4% |
| FY2018 | -$34.7M | -20.9% |
| FY2017 | -$28.7M | -46.8% |
| FY2016 | -$19.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XENE financial trends
XENE RevenueXENE Net incomeXENE Net marginXENE Gross profitXENE Gross marginXENE Operating incomeXENE Operating marginXENE Free cash flowXENE Capital expendituresXENE Return on equityXENE Stock buybacksXENE Dividends paidXENE Total assetsXENE Total liabilitiesXENE Shareholders’ equityXENE overview →